|
1
|
Product specific BE guideline |
Tenofovir Disoproxil Fumarate Tablet_生體相等性試驗指導原則
|
2019-10-01 |
|
2
|
Product specific BE guideline |
Ezetimibe+Simvastatin Tablets_生體相等性試驗指導原則_v2(新增QA)
|
2019-10-01 |
|
3
|
Product specific BE guideline |
Pazopanib tablet_生體相等性試驗指導原則
|
2019-10-01 |
|
4
|
Product specific BE guideline |
Sitagliptin phosphate tablet_生體相等性試驗指導原則
|
2019-10-01 |
|
5
|
Product specific BE guideline |
Ezetimibe Tablets_生體相等性試驗指導原則_v2(新增QA)
|
2019-10-01 |
|
6
|
Product specific BE guideline |
Memantine HCl tablet_生體相等性試驗指導原則
|
2020-07-21 |
|
7
|
Product specific BE guideline |
Zolpidem Tartrate Tablet_生體相等性試驗指導原則
|
2020-07-21 |
|
8
|
Product specific BE guideline |
Dabigatran Etexilate Mesylate Hard Capsules_學名藥生體相等性試驗指導原則
|
2019-01-08 |
|
9
|
Product specific BE guideline |
Agomelatine Tablet_生體相等性試驗指導原則
|
2019-10-01 |
|
10
|
Product specific BE guideline |
Entecavir Tablet_生體相等性試驗指導原則
|
2019-10-01 |
